| 2.8 |
5.6 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 2.6 |
2.6 |
GO:0060769 |
positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
| 2.3 |
7.0 |
GO:0072180 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 2.3 |
6.9 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 2.1 |
6.2 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 1.6 |
1.6 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 1.5 |
6.0 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 1.4 |
4.2 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 1.4 |
5.5 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 1.4 |
4.1 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 1.3 |
4.0 |
GO:0061743 |
motor learning(GO:0061743) |
| 1.2 |
3.7 |
GO:0030421 |
defecation(GO:0030421) |
| 1.2 |
3.5 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 1.2 |
3.5 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 1.1 |
3.3 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.1 |
4.3 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 1.0 |
10.1 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 1.0 |
5.0 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 1.0 |
3.0 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 1.0 |
3.8 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.9 |
4.7 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 0.9 |
4.7 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.9 |
0.9 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.9 |
6.9 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.8 |
4.1 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.8 |
2.4 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.8 |
2.3 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.8 |
2.3 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.8 |
3.0 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.7 |
3.0 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.7 |
2.9 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.7 |
2.1 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.7 |
3.5 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.7 |
3.4 |
GO:0036302 |
atrioventricular canal development(GO:0036302) |
| 0.7 |
10.9 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.7 |
2.7 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.6 |
1.9 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.6 |
1.9 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.6 |
0.6 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.6 |
1.9 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 0.6 |
1.8 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.6 |
1.2 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.6 |
1.8 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.6 |
1.8 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.6 |
2.4 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.6 |
1.7 |
GO:0035907 |
dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
| 0.6 |
2.3 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.6 |
1.7 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.6 |
4.0 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.6 |
1.1 |
GO:2000224 |
testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.6 |
2.3 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.6 |
3.4 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.6 |
5.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.6 |
1.7 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.6 |
1.7 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 |
2.7 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.5 |
2.7 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.5 |
2.1 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
| 0.5 |
1.5 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.5 |
1.5 |
GO:0086017 |
renin secretion into blood stream(GO:0002001) cell communication by chemical coupling(GO:0010643) Purkinje myocyte action potential(GO:0086017) regulation of renin secretion into blood stream(GO:1900133) |
| 0.5 |
1.0 |
GO:0060558 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.5 |
2.0 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 |
1.5 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 |
2.5 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.5 |
2.5 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.5 |
2.9 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.5 |
3.4 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.5 |
2.9 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.5 |
1.4 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.5 |
2.3 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.5 |
4.6 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.4 |
1.7 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.4 |
1.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.4 |
5.6 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.4 |
1.3 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.4 |
1.3 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.4 |
1.3 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.4 |
1.7 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) response to high density lipoprotein particle(GO:0055099) |
| 0.4 |
2.1 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.4 |
1.3 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.4 |
2.5 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.4 |
1.2 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 |
2.0 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.4 |
3.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.4 |
0.4 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.4 |
1.6 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.4 |
0.8 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 |
2.7 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.4 |
1.6 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.4 |
12.0 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.4 |
0.8 |
GO:0034728 |
nucleosome organization(GO:0034728) |
| 0.4 |
1.9 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.4 |
3.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 |
1.9 |
GO:0046864 |
retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) |
| 0.4 |
0.7 |
GO:0072197 |
renal vesicle induction(GO:0072034) ureter morphogenesis(GO:0072197) |
| 0.4 |
4.8 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.4 |
1.8 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.4 |
0.7 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.4 |
3.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
1.0 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.3 |
2.1 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.3 |
1.7 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.3 |
1.3 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.3 |
1.3 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.3 |
3.0 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.3 |
3.3 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.3 |
1.3 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.3 |
2.3 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.3 |
1.3 |
GO:1903898 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.3 |
3.5 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.3 |
2.2 |
GO:1902965 |
establishment of epithelial cell apical/basal polarity(GO:0045198) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.3 |
2.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.3 |
2.8 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.3 |
1.9 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.3 |
0.9 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 |
1.5 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.3 |
1.5 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) |
| 0.3 |
0.3 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.3 |
7.8 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.3 |
0.6 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.3 |
0.9 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.3 |
0.9 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.3 |
2.4 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.3 |
0.9 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.3 |
0.6 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.3 |
0.9 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.3 |
1.5 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.3 |
1.5 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.3 |
3.2 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.3 |
6.9 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.3 |
2.0 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.3 |
2.0 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.3 |
1.1 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.3 |
2.2 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.3 |
0.3 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.3 |
2.7 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.3 |
0.5 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.3 |
3.5 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.3 |
0.5 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.3 |
2.6 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.3 |
1.3 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.3 |
1.8 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.3 |
1.6 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.3 |
1.3 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.3 |
1.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
2.0 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.2 |
0.7 |
GO:1904154 |
protein localization to endoplasmic reticulum exit site(GO:0070973) positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
0.7 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.2 |
1.0 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.2 |
0.5 |
GO:0003289 |
membranous septum morphogenesis(GO:0003149) septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.2 |
0.7 |
GO:1905154 |
negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
| 0.2 |
1.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 |
0.9 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.2 |
2.5 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.2 |
2.2 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.2 |
1.1 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
1.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
0.7 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 |
0.9 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 |
0.9 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.2 |
5.3 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.2 |
0.7 |
GO:0039703 |
viral genome replication(GO:0019079) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.2 |
0.7 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 |
1.5 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.2 |
0.6 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.2 |
1.3 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.2 |
0.4 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
0.6 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.2 |
1.3 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.2 |
0.6 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.2 |
0.6 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.2 |
4.5 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.2 |
0.4 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 0.2 |
1.4 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.2 |
3.0 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.2 |
0.2 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.2 |
2.4 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.2 |
0.6 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
1.2 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.2 |
0.8 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
0.6 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 |
0.8 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.2 |
2.8 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.2 |
1.5 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
2.4 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.2 |
2.2 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.7 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.2 |
2.5 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.2 |
0.4 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.2 |
1.3 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 |
4.4 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.2 |
1.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.2 |
0.3 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.2 |
2.4 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
0.7 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.2 |
1.9 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.2 |
1.3 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.2 |
1.2 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
0.7 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.2 |
1.6 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
0.5 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) orbitofrontal cortex development(GO:0021769) motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) vitamin D3 metabolic process(GO:0070640) positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.2 |
0.6 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.2 |
0.8 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.2 |
0.5 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.2 |
1.0 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 |
0.5 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 |
0.8 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 |
1.1 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
1.1 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
1.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.2 |
0.8 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.2 |
1.5 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
0.6 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 |
3.0 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.7 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of endoribonuclease activity(GO:0060699) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.1 |
1.3 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 |
6.8 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.1 |
1.6 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
1.0 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.1 |
2.2 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
1.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
2.0 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 |
0.7 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
0.7 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.7 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.1 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
1.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.5 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.1 |
0.4 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
1.7 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
0.4 |
GO:0050929 |
corticospinal neuron axon guidance(GO:0021966) corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) regulation of retinal ganglion cell axon guidance(GO:0090259) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.1 |
0.4 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.1 |
0.5 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 |
1.0 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.5 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
1.8 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
2.5 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
1.0 |
GO:0046085 |
IMP metabolic process(GO:0046040) adenosine metabolic process(GO:0046085) |
| 0.1 |
1.0 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 |
0.9 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
0.9 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.5 |
GO:0072235 |
distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
| 0.1 |
1.3 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.1 |
0.5 |
GO:0019042 |
viral latency(GO:0019042) |
| 0.1 |
1.4 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.6 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.4 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.3 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.1 |
0.4 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
2.5 |
GO:0048844 |
artery morphogenesis(GO:0048844) |
| 0.1 |
3.6 |
GO:0007588 |
excretion(GO:0007588) |
| 0.1 |
0.8 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.4 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
0.3 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.1 |
0.1 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.1 |
0.4 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.1 |
2.6 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.1 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 0.1 |
1.4 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 |
0.3 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.1 |
0.4 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 |
0.5 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.2 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.1 |
0.6 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
1.0 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 |
0.2 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.1 |
0.4 |
GO:0061031 |
endodermal digestive tract morphogenesis(GO:0061031) |
| 0.1 |
0.6 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
1.1 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.4 |
GO:0035089 |
establishment of apical/basal cell polarity(GO:0035089) |
| 0.1 |
0.3 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.1 |
1.1 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 |
0.4 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.7 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
1.8 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
0.3 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.1 |
0.4 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
1.9 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.1 |
0.2 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 |
1.5 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.4 |
GO:1901534 |
positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.1 |
0.2 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.1 |
0.3 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.6 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.2 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.1 |
1.0 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.1 |
0.3 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.7 |
GO:0010919 |
regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 |
0.5 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.9 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.4 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 |
1.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.2 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.6 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.7 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.4 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.3 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
1.4 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 |
1.4 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
0.2 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 |
0.3 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
1.9 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.2 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.1 |
1.4 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.1 |
0.8 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.1 |
0.4 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.1 |
0.5 |
GO:0071459 |
protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 |
0.9 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
3.7 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.1 |
1.9 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.1 |
0.3 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.6 |
GO:0099625 |
regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.1 |
1.3 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
0.4 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
0.4 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.1 |
0.5 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 |
1.5 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.1 |
0.4 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
1.7 |
GO:0009168 |
nucleoside monophosphate biosynthetic process(GO:0009124) purine nucleoside monophosphate biosynthetic process(GO:0009127) ribonucleoside monophosphate biosynthetic process(GO:0009156) purine ribonucleoside monophosphate biosynthetic process(GO:0009168) |
| 0.1 |
0.5 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.5 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.1 |
0.5 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.1 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.1 |
0.4 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.7 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
0.3 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.1 |
0.5 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.8 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.1 |
0.7 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.1 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.0 |
0.8 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.0 |
0.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.7 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.1 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) negative regulation of myoblast fusion(GO:1901740) |
| 0.0 |
0.7 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.0 |
0.6 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.6 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.4 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.5 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.0 |
0.6 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
0.5 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.0 |
0.5 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.9 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 |
0.5 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
1.1 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.0 |
1.4 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.3 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.9 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
5.3 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
0.5 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 |
1.2 |
GO:0035307 |
positive regulation of protein dephosphorylation(GO:0035307) |
| 0.0 |
0.8 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.2 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 |
0.0 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.0 |
0.2 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 0.0 |
0.3 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
1.3 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.5 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.0 |
0.5 |
GO:0048048 |
embryonic eye morphogenesis(GO:0048048) |
| 0.0 |
0.6 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.6 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.8 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.0 |
0.1 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.0 |
0.4 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.0 |
0.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.5 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.0 |
1.3 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.6 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.0 |
0.2 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.5 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.4 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 |
1.0 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.5 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
| 0.0 |
0.3 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.3 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.0 |
0.5 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
1.2 |
GO:0048066 |
developmental pigmentation(GO:0048066) |
| 0.0 |
0.9 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
2.7 |
GO:0045137 |
development of primary sexual characteristics(GO:0045137) |
| 0.0 |
0.3 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.0 |
0.3 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.0 |
0.7 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.0 |
0.3 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
1.9 |
GO:0000082 |
G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.0 |
1.0 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.4 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.0 |
0.2 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.4 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.1 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 |
0.4 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.0 |
0.1 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.0 |
0.3 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
1.0 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
0.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
2.0 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
| 0.0 |
0.5 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.0 |
1.1 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.4 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 |
1.3 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.8 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.7 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.3 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.3 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.9 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.1 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.2 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.4 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.7 |
GO:0048144 |
fibroblast proliferation(GO:0048144) |
| 0.0 |
0.4 |
GO:0003382 |
epithelial cell morphogenesis(GO:0003382) |
| 0.0 |
0.4 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
0.1 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.0 |
0.3 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 |
0.3 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
0.5 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.0 |
0.1 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.1 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.0 |
0.1 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 |
0.4 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.2 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 |
0.4 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.9 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.3 |
GO:0001947 |
heart looping(GO:0001947) |
| 0.0 |
0.5 |
GO:0030510 |
regulation of BMP signaling pathway(GO:0030510) |
| 0.0 |
0.2 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 |
0.1 |
GO:0030838 |
positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 |
0.7 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.1 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.8 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
1.7 |
GO:0048863 |
stem cell differentiation(GO:0048863) |
| 0.0 |
0.3 |
GO:0032608 |
interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 0.0 |
0.2 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
0.3 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.0 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.0 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.5 |
GO:0030326 |
embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
| 0.0 |
0.1 |
GO:0019935 |
cAMP-mediated signaling(GO:0019933) cyclic-nucleotide-mediated signaling(GO:0019935) |
| 0.0 |
0.5 |
GO:0032006 |
regulation of TOR signaling(GO:0032006) |
| 0.0 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
